Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Dr Keating Email Interview, page-92

First 92 Last

Share
Profile

Follow
w_i_z_z_a

789 Posts.

155

15/05/16

18:20

Post #: 17771764
Share

Originally posted by Martin Gifford ↑

But as you originally wrote:

“Patients can record and then forward to their doctors their temperature and heart and lung sounds, allowing doctors to listen for lung findings associated with pneumonia and asthma,”

Sounds great right? But now imagine removing the $149 Purchase and being able to do this more accurately with no additional hardware and you start seeing the potential of “ResApp”..

Clearly, doctors might use the other product first, then decide that it isn't pneumonia or asthma, in which case Resapp won't get used. Certainly, as Resapp becomes available for other diseases, it would close the gap. Also, people on these threads have mentioned some doctors disliking the idea of a diagnostic coughing app, so those old-school doctors would be tempted to use the old product ahead of the app.

Expand

Doubt it, older generation doctors still go with 'evidenced based medicine' and order the most appropriate investigation.
Just 1 example, CTPA vs VQ scan.

RAP Price at posting: 25.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

There are more pages in this discussion • 16 more messages in this thread...

First 92 Last

Add RAP (ASX) to my watchlist